Table 1.
Antimicrobial resistance rate | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bacterial | CEF | CHL | CIP | CLI | ERY | GEN | PEN | OXA | SXT | TEI | TET | VAN |
Staphylococcus aureus | 4.2% | 24.3% | 73.1% | 70.3% | 84.6% | 60.3% | 96.3% | 68.9% | 35.0% | 4.8% | 61.3% | 0.8% |
CNS | 47.7% | 34.6% | 67.1% | 65.3% | 82.5% | 51.9% | 89.7% | 82.7% | 50.6% | 2.0% | 55.0% | 0.7% |
Total | 19.4% | 27.9% | 71.0% | 68.5% | 83.9% | 57.4% | 94.0% | 73.7% | 40.5% | 3.8% | 59.1% | 0.7% |
Twelve antibiotics were used in establishing the level of antimicrobial resistance among the Staphylococcus aureus (1,131 strains) and CNS isolates (608 strains). The antibiotics examined included CEF, cefoxitin (30 μg); CHL, chloramphenicol (30 μg); CIP, ciprofloxacin (5 μg); CLI, clindamycin (2 μg); ERY, erythromycin (15 μg); GEN, gentamicin (10 μg); OXA, oxacillin (1 μg); PEN, penicillin (10 μg); SXT, trimethoprim–sulfamethoxazole (1.25/23.75 μg); TEI, teicoplanin (30 μg); TET, tetracycline (30 μg); VAN, vancomycin (30 μg).
CNS, coagulase-negative staphylococci.